Shares of Novavax Inc. NVAX, + 5.66% rally took 2.8% in premier trading Thursday after the biotechnology company said it had concluded a development and supply agreement with South Korea-based SK Group subsidiary SK Bioscience for the antigen component of Novavax’s COVID-19 vaccine candidate, NVX-CoV2373. The companies have also signed …
Read More »Novavax share launch after offering deal with South Korean SK group for COVID-19 vaccine candidate
